Sweet trail of Halloween fun for families at Orrville s Fall Festival
the-daily-record.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from the-daily-record.com Daily Mail and Mail on Sunday newspapers.
Darin Johnson breaks down what code switching is
upenn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from upenn.edu Daily Mail and Mail on Sunday newspapers.
Times Report
After two years as vice president, Mike Skaug was named president of the Minnesota Soybean Growers Association Monday during the nonpartisan’s organization first in-person board meeting in more than a year.
“I’m humbled and honored my fellow directors have put their confidence in me to lead this storied organization,” said Skaug, who’s helped lead MSGA’s advocacy strategizing in St. Paul. “I’m eager to hit the ground running to advocate for our members and promote policies that will improve the profitability outlook for Minnesota farmers.”
Skaug (prounounced S-cow ) is also chair of the Ag Innovation Campus in Crookston. He farms alongside his son, Ryan, on their fifth-generation farm in Polk County. He joined the MSGA board in 2012 and later served as treasurer before becoming vice president in 2019. Skaug replaces Jamie Beyer, who stepped down after two years as president.
RTI Surgical and Exactech Announce Strategic Partnership
News provided by
Share this article
Share this article
ALACHUA, Fla., July 13, 2021 /PRNewswire/ RTI Surgical, a leading surgical implant company providing blue-chip OEM customers with a portfolio of tissue-based, synthetic and metal implants, has today announced it has entered in a long-term strategic agreement with leading global medical device OEM Exactech, related to the development and supply of biologic bone substitutes.
As part of the agreement, RTI Surgical has acquired Exactech s Optecure®, a 510(k)- cleared demineralized bone matrix for use as a bone graft extender in the spine, pelvis, and extremities. Optecure® will complement RTI Surgical s market-leading portfolio of bone graft substitutes.